These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36358570)

  • 21. Manganese porphyrin reduces renal injury and mitochondrial damage during ischemia/reperfusion.
    Saba H; Batinic-Haberle I; Munusamy S; Mitchell T; Lichti C; Megyesi J; MacMillan-Crow LA
    Free Radic Biol Med; 2007 May; 42(10):1571-8. PubMed ID: 17448904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Redox-Active Mn Porphyrin-based Potent SOD Mimic, MnTnBuOE-2-PyP(5+), Enhances Carbenoxolone-Mediated TRAIL-Induced Apoptosis in Glioblastoma Multiforme.
    Yulyana Y; Tovmasyan A; Ho IA; Sia KC; Newman JP; Ng WH; Guo CM; Hui KM; Batinic-Haberle I; Lam PY
    Stem Cell Rev Rep; 2016 Feb; 12(1):140-55. PubMed ID: 26454429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential localization and potency of manganese porphyrin superoxide dismutase-mimicking compounds in Saccharomyces cerevisiae.
    Li AM; Martins J; Tovmasyan A; Valentine JS; Batinic-Haberle I; Spasojevic I; Gralla EB
    Redox Biol; 2014; 3():1-6. PubMed ID: 25462059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipophilicity is a critical parameter that dominates the efficacy of metalloporphyrins in blocking the development of morphine antinociceptive tolerance through peroxynitrite-mediated pathways.
    Batinić-Haberle I; Ndengele MM; Cuzzocrea S; Rebouças JS; Spasojević I; Salvemini D
    Free Radic Biol Med; 2009 Jan; 46(2):212-9. PubMed ID: 18983908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mn-porphyrins as novel molecular magnetic resonance imaging contrast agents.
    Mouraviev V; Venkatraman TN; Tovmasyan A; Kimura M; Tsivian M; Mouravieva V; Polascik TJ; Wang H; Amrhein TJ; Batinic-Haberle I; Lascola C
    J Endourol; 2011 Nov; ():1420-4. PubMed ID: 22050509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Manganese porphyrin redox state in endothelial cells: Resonance Raman studies and implications for antioxidant protection towards peroxynitrite.
    Carballal S; Valez V; Alvarez-Paggi D; Tovmasyan A; Batinic-Haberle I; Ferrer-Sueta G; Murgida DH; Radi R
    Free Radic Biol Med; 2018 Oct; 126():379-392. PubMed ID: 30144631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrostatic contribution in the catalysis of O2*- dismutation by superoxide dismutase mimics. MnIIITE-2-PyP5+ versus MnIIIBr8T-2-PyP+.
    Spasojevic I; Batinic-Haberle I; Reboucas JS; Idemori YM; Fridovich I
    J Biol Chem; 2003 Feb; 278(9):6831-7. PubMed ID: 12475974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticancer therapeutic potential of Mn porphyrin/ascorbate system.
    Tovmasyan A; Sampaio RS; Boss MK; Bueno-Janice JC; Bader BH; Thomas M; Reboucas JS; Orr M; Chandler JD; Go YM; Jones DP; Venkatraman TN; Haberle S; Kyui N; Lascola CD; Dewhirst MW; Spasojevic I; Benov L; Batinic-Haberle I
    Free Radic Biol Med; 2015 Dec; 89():1231-47. PubMed ID: 26496207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism.
    Yang Y; Deng Y; Chen X; Zhang J; Chen Y; Li H; Wu Q; Yang Z; Zhang L; Liu B
    Toxicol Lett; 2018 Oct; 295():88-98. PubMed ID: 29857117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spinal mitochondrial-derived peroxynitrite enhances neuroimmune activation during morphine hyperalgesia and antinociceptive tolerance.
    Little JW; Cuzzocrea S; Bryant L; Esposito E; Doyle T; Rausaria S; Neumann WL; Salvemini D
    Pain; 2013 Jul; 154(7):978-86. PubMed ID: 23590939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allicin Overcomes Hypoxia Mediated Cisplatin Resistance in Lung Cancer Cells through ROS Mediated Cell Death Pathway and by Suppressing Hypoxia Inducible Factors.
    Pandey N; Tyagi G; Kaur P; Pradhan S; Rajam MV; Srivastava T
    Cell Physiol Biochem; 2020 Aug; 54(4):748-766. PubMed ID: 32809300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bisdemethoxycurcumin sensitizes the response of cisplatin resistant non-small cell lung carcinoma cell lines by activating apoptosis and autophagy.
    Klingseisen V; Slanovc J; Regouc M; Hrzenjak A
    J Nutr Biochem; 2022 Aug; 106():109003. PubMed ID: 35346827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inactivation of AKT/NF‑κB signaling by eurycomalactone decreases human NSCLC cell viability and improves the chemosensitivity to cisplatin.
    Dukaew N; Chairatvit K; Pitchakarn P; Imsumran A; Karinchai J; Tuntiwechapikul W; Wongnoppavich A
    Oncol Rep; 2020 Oct; 44(4):1441-1454. PubMed ID: 32945500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isorhamnetin flavonoid synergistically enhances the anticancer activity and apoptosis induction by cis-platin and carboplatin in non-small cell lung carcinoma (NSCLC).
    Zhang BY; Wang YM; Gong H; Zhao H; Lv XY; Yuan GH; Han SR
    Int J Clin Exp Pathol; 2015; 8(1):25-37. PubMed ID: 25755690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the compounds commonly known as superoxide dismutase and catalase mimics in cellular models.
    Vincent A; Thauvin M; Quévrain E; Mathieu E; Layani S; Seksik P; Batinic-Haberle I; Vriz S; Policar C; Delsuc N
    J Inorg Biochem; 2021 Jun; 219():111431. PubMed ID: 33798828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phloretin exhibits an anticancer effect and enhances the anticancer ability of cisplatin on non-small cell lung cancer cell lines by regulating expression of apoptotic pathways and matrix metalloproteinases.
    Ma L; Wang R; Nan Y; Li W; Wang Q; Jin F
    Int J Oncol; 2016 Feb; 48(2):843-53. PubMed ID: 26692364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Redox modulation of oxidative stress by Mn porphyrin-based therapeutics: the effect of charge distribution.
    Rebouças JS; Spasojević I; Tjahjono DH; Richaud A; Méndez F; Benov L; Batinić-Haberle I
    Dalton Trans; 2008 Mar; (9):1233-42. PubMed ID: 18283384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetyl-11-keto-β-boswellic acid enhances the cisplatin sensitivity of non-small cell lung cancer cells through cell cycle arrest, apoptosis induction, and autophagy suppression via p21-dependent signaling pathway.
    Lv M; Zhuang X; Zhang Q; Cheng Y; Wu D; Wang X; Qiao T
    Cell Biol Toxicol; 2021 Apr; 37(2):209-228. PubMed ID: 32562082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD44 variant-dependent regulation of redox balance in EGFR mutation-positive non-small cell lung cancer: A target for treatment.
    Kawano Y; Iwama E; Tsuchihashi K; Shibahara D; Harada T; Tanaka K; Nagano O; Saya H; Nakanishi Y; Okamoto I
    Lung Cancer; 2017 Nov; 113():72-78. PubMed ID: 29110853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salinomycin enhances cisplatin-induced cytotoxicity in human lung cancer cells via down-regulation of AKT-dependent thymidylate synthase expression.
    Ko JC; Zheng HY; Chen WC; Peng YS; Wu CH; Wei CL; Chen JC; Lin YW
    Biochem Pharmacol; 2016 Dec; 122():90-98. PubMed ID: 27666600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.